Source: Annual Congress 2013 –COPD treatment and others
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Feshchenko, L. Iashyna, M. Polianska, I. Zvol, A. Potocjniak, L. Savelieva (Kiev, Ukraine). Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode. Eur Respir J 2013; 42: Suppl. 57, 3653

Member's Comments

No comment yet.

Related content which might interest you: Peculiar properties of sleep structure and impact of antidepressive therapy in COPD patients with concomitant depressive episode Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Prevalence and characteristics of anxiety and depression in patients with advanced COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 The relationship between depression, medication and stage of the disease in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Assessment of treatment efficiency in patients with chronic obstructive pulmonary disease combined with gastroesophageal reflux disease during treatment with melatonin Source: International Congress 2014 – Clinical presentations Year: 2014 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Use of inhaled corticosteroids and the risk of depressive symptoms in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease Source: International Congress 2014 – COPD: points to ponder Year: 2014 The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations Source: Eur Respir J 2013; 41: 815-823 Year: 2013 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability Source: International Congress 2014 – Markers Year: 2014 Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Psychiatric co-morbidity in patients admitted with acute exacerbation of chronic pulmonary disease and its relationship with symptom severity Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006